H-1B Sponsors for Chemists
76 employers filed 4,744 H-1B Labor Condition Applications for Chemists across the US between FY2010 and FY2026. The 50 largest are ranked below, with DOL certification outcomes and a sponsor-health signal.
- Employers
- 76top 50 listed
- Filings
- 4,74424% of all 19,513 for this role
- Certified
- 92.3%across those listed
- Median wage
- $65,000across the sponsors listed
How this total is counted: filings from employers with at least 25 for this occupation, a resolved employer and a recorded worksite state. That is 4,744 of the 19,513 total shown on the Chemists occupation page (24%); the remainder is the long tail of employers below the publishing threshold.
How to read this
- Does an H-1B filing mean a visa was granted?
- No. A Labor Condition Application is the wage-and-worksite filing an employer makes before petitioning. Many certified LCAs never become petitions, and an LCA is not a visa. What an LCA is.
- Is a certified filing the same as USCIS approval?
- No. Certification is a Department of Labor outcome. The I-129 petition is decided separately by USCIS and is not in this dataset. How certification rate works.
- Does a withdrawn filing count against a sponsor?
- No. A withdrawal usually means the role was filled or dropped, so it is not a compliance signal and is not counted against a sponsor in the sponsor-health score. How sponsor health is calculated.
- Is the wage shown what an employee takes home?
- No. Offered and prevailing wages are the figures on the filing, before tax, bonus or equity, and they describe the role rather than an individual paycheck. How the prevailing wage works.
- Is the most recent fiscal year complete?
- Not necessarily. The Department of Labor releases disclosure data quarterly, so counts for the latest fiscal years can still rise in a later release.
- Why are some occupations or states missing?
- Combinations backed by fewer than 25 filings, or fewer than 3 distinct employers, are not published at all. Small cells are omitted entirely rather than shown with unreliable numbers.
Top 50 sponsors, ranked
The 50 highest-volume of 76 employers that filed for this role here. Filter and sort instantly — everything below is already on the page, so nothing reloads. Your view is shareable: the URL updates as you filter.
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.
Showing 50 of 50 sponsors · all filings FY2010–FY2026.
| # | Wage levels | |||||
|---|---|---|---|---|---|---|
| 1 | SCIEGEN PHARMACEUTICALS, INC. | 243 | 97.5% | $52,000 | Prevailing-wage level mix — Level I: 54%, Level II: 26%, Level III: 15%, Level IV: 5% | |
| 2 | INVAGEN PHARMACEUTICALS, INC. | 191 | 98.4% | $50,000 | Prevailing-wage level mix — Level I: 57%, Level II: 21%, Level III: 14%, Level IV: 7% | |
| 3 | APPCO Pharma LLC | 173 | 90.2% | $57,075 | Prevailing-wage level mix — Level I: 62%, Level II: 33%, Level III: 5% | |
| 4 | Novel Laboratories, Inc. | 173 | 96.0% | $51,064 | Prevailing-wage level mix — Level I: 14%, Level II: 71%, Level III: 14% | |
| 5 | THE DOW CHEMICAL COMPANYlast filed FY2019 | 169 | 81.1% | $88,152 | — | |
| 6 | ASCENT PHARMACEUTICALS, INC. | 155 | 99.4% | $55,000 | Prevailing-wage level mix — Level I: 63%, Level II: 28%, Level III: 9% | |
| 7 | BACTOLAC PHARMACEUTICAL INC. | 150 | 97.3% | $51,750 | Prevailing-wage level mix — Level I: 33%, Level II: 33%, Level III: 33% | |
| 8 | KVK-Tech, Inc. | 142 | 97.2% | $56,451 | Prevailing-wage level mix — Level I: 9%, Level II: 65%, Level III: 17%, Level IV: 9% | |
| 9 | Lawrence Berkeley National Laboratory | 133 | 90.2% | $67,548 | Prevailing-wage level mix — Level III: 100% | |
| 10 | PharmaCare U.S., Inc.last filed FY2018 | 131 | 83.2% | $55,000 | — | |
| 11 | NOVITIUM PHARMA LLC. | 122 | 88.5% | $65,770 | Prevailing-wage level mix — Level I: 17%, Level II: 54%, Level III: 17%, Level IV: 11% | |
| 12 | AKORN (NEW JERSEY), INC.last filed FY2019 | 120 | 95.8% | $72,000 | — | |
| 13 | Brookhaven National Laboratory | 119 | 91.6% | $79,800 | Prevailing-wage level mix — Level I: 3%, Level II: 97% | |
| 14 | Battelle Memorial Institute | 100 | 70.0% | $90,730 | Prevailing-wage level mix — Level I: 69%, Level II: 20%, Level III: 7%, Level IV: 4% | |
| 15 | Sun Pharmaceutical Industries, Inc. | 98 | 94.9% | $64,557 | Prevailing-wage level mix — Level III: 100% | |
| 16 | Tris Pharma, Inc. | 93 | 94.6% | $51,022 | Prevailing-wage level mix — Level I: 29%, Level II: 36%, Level III: 21%, Level IV: 14% | |
| 17 | Gilead Sciences, Inc. | 85 | 97.6% | $104,915 | Prevailing-wage level mix — Level I: 3%, Level II: 36%, Level III: 31%, Level IV: 31% | |
| 18 | Guardian Drug Company, Inc. | 84 | 94.0% | $65,000 | Prevailing-wage level mix — Level I: 61%, Level II: 30%, Level III: 4%, Level IV: 4% | |
| 19 | Belcher Pharmaceuticals, LLC | 76 | 97.4% | $55,000 | Prevailing-wage level mix — Level I: 13%, Level II: 33%, Level III: 27%, Level IV: 27% | |
| 20 | Argus Information and Advisory Services LLClast filed FY2018 | 74 | 98.6% | $65,000 | — | |
| 21 | Vertex Pharmaceuticals Incorporated | 73 | 90.4% | $91,978 | Prevailing-wage level mix — Level I: 16%, Level II: 56%, Level III: 16%, Level IV: 13% | |
| 22 | AMNEAL PHARMACEUTICALS OF NY LLC | 60 | 95.0% | $55,000 | Prevailing-wage level mix — Level I: 43%, Level II: 29%, Level III: 29% | |
| 23 | AMNEAL PHARMACEUTICALS LLC | 59 | 93.2% | $54,570 | Prevailing-wage level mix — Level II: 30%, Level III: 30%, Level IV: 40% | |
| 24 | AbbVie Inc. | 58 | 98.3% | $106,250 | Prevailing-wage level mix — Level III: 38%, Level IV: 63% | |
| 25 | Tergus Pharma, LLC | 56 | 89.3% | $54,000 | Prevailing-wage level mix — Level I: 9%, Level II: 9%, Level III: 45%, Level IV: 36% | |
| 26 | Sannova Analytical LLC | 55 | 98.2% | $64,449 | Prevailing-wage level mix — Level I: 40%, Level II: 40%, Level III: 20% | |
| 27 | PPG Industries, Inc. | 54 | 98.1% | $86,415 | Prevailing-wage level mix — Level I: 14%, Level II: 9%, Level III: 23%, Level IV: 55% | |
| 28 | Chemtex Environmental Laboratory, Inc.last filed FY2018 | 53 | 86.8% | $49,046 | — | |
| 29 | Advanced Technology Laboratories Inc. | 50 | 92.0% | $43,555 | Prevailing-wage level mix — Level I: 100% | |
| 30 | FAIR ISAAC CORPORATION | 48 | 87.5% | $89,315 | Prevailing-wage level mix — Level III: 20%, Level IV: 80% | |
| 31 | Genentech, Inc. | 47 | 66.0% | $87,818 | Prevailing-wage level mix — Level I: 9%, Level II: 36%, Level III: 27%, Level IV: 27% | |
| 32 | Med-Pharmex, Inc.last filed FY2018 | 47 | 97.9% | $50,000 | — | |
| 33 | Merck Sharp & Dohme LLC | 46 | 84.8% | $111,400 | Prevailing-wage level mix — Level II: 52%, Level III: 39%, Level IV: 9% | |
| 34 | Navinta LLC | 45 | 97.8% | $75,000 | Prevailing-wage level mix — Level II: 92%, Level III: 8% | |
| 35 | RK PHARMA INC | 45 | 100.0% | $63,086 | Prevailing-wage level mix — Level I: 76%, Level II: 20%, Level IV: 4% | |
| 36 | Rutgers, The State University of New Jerseylast filed FY2017 | 45 | 80.0% | $44,963 | — | |
| 37 | Allure Labs, LLC | 44 | 93.2% | $60,000 | Prevailing-wage level mix — Level I: 10%, Level II: 90% | |
| 38 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 42 | 97.6% | $80,912 | Prevailing-wage level mix — Level III: 100% | |
| 39 | The Sherwin-Williams Company | 41 | 90.2% | $70,000 | Prevailing-wage level mix — Level III: 50%, Level IV: 50% | |
| 40 | Eli Lilly and Company | 39 | 89.7% | $114,800 | Prevailing-wage level mix — Level II: 19%, Level III: 28%, Level IV: 53% | |
| 41 | SAS Institute Inc.last filed FY2019 | 39 | 100.0% | $92,401 | — | |
| 42 | 3M Companylast filed FY2018 | 38 | 94.7% | $94,328 | — | |
| 43 | Google LLC | 38 | 89.5% | $124,000 | Prevailing-wage level mix — Level II: 35%, Level III: 41%, Level IV: 24% | |
| 44 | LNK International, Inc. | 38 | 100.0% | $65,000 | Prevailing-wage level mix — Level I: 97%, Level II: 3% | |
| 45 | Teva Pharmaceuticals USA, Inc.last filed FY2019 | 38 | 73.7% | $99,000 | — | |
| 46 | Merck & Co. Inc.last filed FY2013 | 36 | 83.3% | $66,602 | — | |
| 47 | Henkel Corporation | 35 | 94.3% | $76,950 | Prevailing-wage level mix — Level II: 33%, Level III: 56%, Level IV: 11% | |
| 48 | KASHIV SPECIALTY PHARMACEUTICALS, LLClast filed FY2018 | 35 | 82.9% | $58,000 | — | |
| 49 | APICORE LLC | 34 | 94.1% | $62,920 | Prevailing-wage level mix — Level II: 33%, Level III: 33%, Level IV: 33% | |
| 50 | Incyte Corporation | 33 | 97.0% | $118,450 | Prevailing-wage level mix — Level I: 5%, Level II: 15%, Level III: 45%, Level IV: 35% |
- Filings
- 243
- Certified
- 97.5%
- Median wage
- $52,000
- Filings
- 191
- Certified
- 98.4%
- Median wage
- $50,000
- Filings
- 173
- Certified
- 90.2%
- Median wage
- $57,075
- Filings
- 173
- Certified
- 96.0%
- Median wage
- $51,064
- Filings
- 169
- Certified
- 81.1%
- Median wage
- $88,152
- Filings
- 155
- Certified
- 99.4%
- Median wage
- $55,000
- Filings
- 150
- Certified
- 97.3%
- Median wage
- $51,750
- Filings
- 142
- Certified
- 97.2%
- Median wage
- $56,451
- Filings
- 133
- Certified
- 90.2%
- Median wage
- $67,548
- Filings
- 131
- Certified
- 83.2%
- Median wage
- $55,000
- Filings
- 122
- Certified
- 88.5%
- Median wage
- $65,770
- Filings
- 120
- Certified
- 95.8%
- Median wage
- $72,000
- Filings
- 119
- Certified
- 91.6%
- Median wage
- $79,800
- Filings
- 100
- Certified
- 70.0%
- Median wage
- $90,730
- Filings
- 98
- Certified
- 94.9%
- Median wage
- $64,557
- Filings
- 93
- Certified
- 94.6%
- Median wage
- $51,022
- Filings
- 85
- Certified
- 97.6%
- Median wage
- $104,915
- Filings
- 84
- Certified
- 94.0%
- Median wage
- $65,000
- Filings
- 76
- Certified
- 97.4%
- Median wage
- $55,000
- Filings
- 74
- Certified
- 98.6%
- Median wage
- $65,000
- Filings
- 73
- Certified
- 90.4%
- Median wage
- $91,978
- Filings
- 60
- Certified
- 95.0%
- Median wage
- $55,000
- Filings
- 59
- Certified
- 93.2%
- Median wage
- $54,570
- Filings
- 58
- Certified
- 98.3%
- Median wage
- $106,250
- Filings
- 56
- Certified
- 89.3%
- Median wage
- $54,000
- Filings
- 55
- Certified
- 98.2%
- Median wage
- $64,449
- Filings
- 54
- Certified
- 98.1%
- Median wage
- $86,415
- Filings
- 53
- Certified
- 86.8%
- Median wage
- $49,046
- Filings
- 50
- Certified
- 92.0%
- Median wage
- $43,555
- Filings
- 48
- Certified
- 87.5%
- Median wage
- $89,315
- Filings
- 47
- Certified
- 66.0%
- Median wage
- $87,818
- Filings
- 47
- Certified
- 97.9%
- Median wage
- $50,000
- Filings
- 46
- Certified
- 84.8%
- Median wage
- $111,400
- Filings
- 45
- Certified
- 97.8%
- Median wage
- $75,000
- Filings
- 45
- Certified
- 100.0%
- Median wage
- $63,086
- Filings
- 45
- Certified
- 80.0%
- Median wage
- $44,963
- Filings
- 44
- Certified
- 93.2%
- Median wage
- $60,000
- Filings
- 42
- Certified
- 97.6%
- Median wage
- $80,912
- Filings
- 41
- Certified
- 90.2%
- Median wage
- $70,000
- Filings
- 39
- Certified
- 89.7%
- Median wage
- $114,800
- Filings
- 39
- Certified
- 100.0%
- Median wage
- $92,401
- Filings
- 38
- Certified
- 94.7%
- Median wage
- $94,328
- Filings
- 38
- Certified
- 89.5%
- Median wage
- $124,000
- Filings
- 38
- Certified
- 100.0%
- Median wage
- $65,000
- Filings
- 38
- Certified
- 73.7%
- Median wage
- $99,000
- Filings
- 36
- Certified
- 83.3%
- Median wage
- $66,602
- Filings
- 35
- Certified
- 94.3%
- Median wage
- $76,950
- Filings
- 35
- Certified
- 82.9%
- Median wage
- $58,000
- Filings
- 34
- Certified
- 94.1%
- Median wage
- $62,920
- Filings
- 33
- Certified
- 97.0%
- Median wage
- $118,450
How the sponsor-health signal is calculated
The badge blends each sponsor’s DOL certification rate (weighted toward the last five fiscal years), its denial rate, and its recent filing volume. Withdrawn filings are not counted against a sponsor, because a withdrawal usually means the role was filled or dropped. Sponsors with too few or too old filings show “Limited data” rather than a score. It reflects DOL paperwork outcomes only — not USCIS approval, pay quality, or an endorsement. Full methodology.
Where else Chemists is sponsored
Other states with enough Chemists filings to publish a sponsor breakdown.